logo

TARA

Protara Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

TARA fundamentals

Protara Therapeutics (TARA) released its earnings on Nov 10, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.31 (YoY +38.00%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.31
+38.00%
Report date
Nov 10, 2025
EPS
Revenue

Revenue & Expenses

Key Indicators

Protara Therapeutics (TARA) key financial stats and ratios, covering profitability, financial health, and leverage.
Protara Therapeutics (TARA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Protara Therapeutics (TARA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Protara Therapeutics (TARA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Protara Therapeutics (TARA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Protara Therapeutics (TARA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield